Comparision of Sankara Sweda, Virechana Karma and Basti Karma with Vaishwanara Churna orally in the treatment of Amavata(Rheumatoid arthritis)

Effect of Sankara Sweda, Virechana Karma and Basti Karma followed by Vaishwanara Churna in the management of Amavata w.s.r. to Rheumatoid arthritis: An Open Labelled Randomized Comparative Clinical Trial - SWEVIRBA

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/10/028625

Enrollment

Registered

2020-10-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention1: Sankara sweda for 7 days followed by virechana Karma with virechana yoga followed by Vaishwanara churna as shamana aushadha for 14 days: In group A patient will undergo first sankar swe

Eligibility

Inclusion criteria

Inclusion criteria: (1) Patients of either sex with age between 18 and 60 years. (2) Willing and able to participate in the study. (3) Patient having signs & symptoms of Amavata w.s.r Rheumatoid arthritis with fulfilling Diagnostic criteria. (4) Chronicity: less than 10 years. (5) Patients with post-chikungunya Rheumatoid arthritis will be included if fulfilling ACR diagnostic criteria. (6) Patient fit and willing for Virechana Karma and Basti Karma in respective group.

Exclusion criteria

Exclusion criteria: (1) Patients having severe systemic diseases like cardiac disorders and Cancer. (2) Patients below 18 years and above 60 years. (3) Pregnant/lactating women. (4) Chronicity: more than 10 years. (5) Patient not fit for Virechana Karma or Basti Karma in respective group. (6) Patients having Gouty arthritis.

Design outcomes

Primary

Measure	Time frame
Relief in sign and symptoms of AmavataTimepoint: after the follow up period	—

Secondary

Measure	Time frame
Improves quality of life of the patientTimepoint: after the follow up period	—

Countries

India

Contacts

Public ContactProf Anup Thakar

IPGT and RA

anup_thakar@yahoo.com9427776660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026